Navigation Links
Thomson Reuters and the National Foundation for Cancer Research Provide Online Help for Cancer Patients
Date:4/22/2009

NexCura Cancer Profiler Tools Provide Patients with Treatment Information on www.nfcr.org

ANN ARBOR, Mich., April 22 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced today that it will incorporate NexCura(R) Cancer Profiler Tools from Thomson Reuters into its Web site.

The 20 online tools will provide cancer patients with critical, customized information about their treatment options.

"We are excited to provide a unique service like this to patients dealing with the stresses and questions that come with the diagnosis of cancer," said Franklin C. Salisbury, Jr., president of NFCR. "These tools empower cancer patients with the information they need but can't always easily find. These patients are under enough stress without having to experience difficulty in finding the information they need."

Alicia Moffat, vice president of Web operations for the Healthcare business of Thomson Reuters, explains: "The tools were created using patented technology that guides users through a step-by-step questionnaire to match the patient's diagnosis, diagnostic results, and disease stage with the relevant treatment options." All information provided by the NexCura Cancer Profiler Tools is peer-reviewed.

NFCR offers the NexCura Cancer Profiler under the Treatment Decision Tools section of its Web site (http://www.nfcr.org/patientsupport). The NexCura Cancer Profiler is the only online service generating comprehensive treatment information that is personalized for specific diagnoses and clinical status. The customized information enables patients to better communicate with their doctors and care teams and, through education, encourages the patient to play a more proactive role in treatment decisions.

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance and enhance the quality of healthcare. Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.

About NFCR

The National Foundation for Cancer Research has supported cutting-edge cancer research to advance personalized medicine and targeted therapies for over three decades. As a leading cancer charity, NFCR is dedicated to funding scientists who are discovering cancer's molecular mysteries and translating these discoveries into therapies that hold the hope for curing cancer. NFCR brings the most advanced medical resources to oncologists and health professionals to help guide their treatment decisions for patients worldwide. For more information, visit www.nfcr.org.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Thomson Acquires Prous Science
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. Thomson Scientific Ranks Australian Universities and Research Institutes
9. Thomson Scientific Launches Confessions ... of a User Campaign Asking Are You the New Face of Research?
10. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
11. Thomson Healthcare Launches Application That Assesses Physician Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using ... Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          ... boosting quality. , It’s known as the “CY2016 Annual FDA Medical Device Quality ...
(Date:7/20/2017)... ... 2017 , ... The Business Architecture Guild® is pleases to ... )v 6.0 is now available for member download. This release is dedicated to ... Non-members may download the Part 1 Introduction for free at http://www.businessarchitectureguild.org. ...
(Date:7/20/2017)... ... July 19, 2017 , ... A local summer ... increased funds raised to support fine arts programs in Chester County’s Elementary Schools. ... Freed-Hardeman University’s Loyd Auditorium. , More than 850 people attended the two ...
(Date:7/20/2017)... ... July 19, 2017 , ... ... million Health Resources and Services Administration (HRSA) grant to train predoctoral dental students ... care needs in rural and underserved areas. , The Predoctoral Pediatric Training Project ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: